{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T21:50:39Z","timestamp":1698702639620},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,15]]},"DOI":"10.1093\/infdis\/jiq121","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T18:38:22Z","timestamp":1298399902000},"page":"847-853","source":"Crossref","is-referenced-by-count":9,"title":["Loss of Virus-specific T-Cell Responses in HCV Exposed Uninfected Injection Drug Users With Drug Rehabilitation"],"prefix":"10.1093","volume":"203","author":[{"given":"Prem H.","family":"Thurairajah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doha","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Demaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward R.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Cramp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"key\n\t\t\t\t20170702152511_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21765","article-title":"Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000","volume":"46","author":"Tseng","year":"2007","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170702152511_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2249.2008.03655.x","article-title":"Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection","volume":"152","author":"Hegazy","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20170702152511_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2893.2008.01016.x","article-title":"Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users","volume":"16","author":"Zeremski","year":"2009","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20170702152511_bib4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/593337","article-title":"Hepatitis C virus (HCV)\u2013specific T cell responses in injection drug users with apparent resistance to HCV infection","volume":"198","author":"Thurairajah","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702152511_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/422605","article-title":"Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use","volume":"190","author":"Freeman","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702152511_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/516546","article-title":"Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons","volume":"176","author":"Koziel","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702152511_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1743-422X-4-58","article-title":"Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response","volume":"4","author":"Meyer","year":"2007","journal-title":"Virol J"},{"key":"key\n\t\t\t\t20170702152511_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/589510","article-title":"Hepatitis C virus (HCV)\u2013specific immune responses of long-term injection drug users frequently exposed to HCV","volume":"198","author":"Mizukoshi","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702152511_bib9","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/383279","article-title":"Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort","volume":"189","author":"Post","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702152511_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.321.7253.78","article-title":"Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey","volume":"321","author":"Allwright","year":"2000","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170702152511_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S0950268803001882","article-title":"The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities","volume":"132","author":"Hellard","year":"2004","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20170702152511_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1360-0443.1998.9322438.x","article-title":"A survey of bloodborne viruses and associated risk behaviours in Greek prisons","volume":"93","author":"Malliori","year":"1998","journal-title":"Addiction"},{"key":"key\n\t\t\t\t20170702152511_bib13","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ije\/26.6.1359","article-title":"History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin","volume":"26","author":"Stark","year":"1997","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20170702152511_bib14","first-page":"121","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey","volume":"3","author":"Weild","year":"2000","journal-title":"Commun Dis Public Health"},{"key":"key\n\t\t\t\t20170702152511_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bmj.315.7099.21","article-title":"Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison","volume":"315","author":"Bird","year":"1997","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170702152511_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1024603517136","article-title":"Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity","volume":"18","author":"Backmund","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t20170702152511_bib17","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"1","author":"Garfein","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key\n\t\t\t\t20170702152511_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0950268806007035","article-title":"Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them","volume":"135","author":"Roy","year":"2007","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20170702152511_bib19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1172\/JCI12433","article-title":"CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects","volume":"107","author":"Kaul","year":"2001","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170702152511_bib20","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1097\/00002030-200410210-00015","article-title":"HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis","volume":"18","author":"Kaul","year":"2004","journal-title":"AIDS"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/203\/6\/847\/18064738\/jiq121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T13:16:28Z","timestamp":1503494188000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiq121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,3,15]]},"published-print":{"date-parts":[[2011,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiq121","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}